Logo image of NGMD.CA

NUGEN MEDICAL DEVICES INC (NGMD.CA) Stock Analyst Earnings Estimates

TSX-V:NGMD - TSX Venture Exchange - CA67054F1009 - Common Stock - Currency: CAD

0.06  0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
NGMD.CA revenue by date.NGMD.CA revenue by date.
137.7K152.4K
10.68%		331.4K
117.45%
EBITDA
YoY % growth
NGMD.CA ebitda by date.NGMD.CA ebitda by date.
-6.881M-4.142M
39.81%		-7.357M
-77.64%
EBIT
YoY % growth
NGMD.CA ebit by date.NGMD.CA ebit by date.
-7.671M-4.794M
37.51%		-8.048M
-67.88%
Operating Margin
NGMD.CA operating margin by date.NGMD.CA operating margin by date.
-5,571.02%-3,145.67%-2,428.52%
EPS
YoY % growth
NGMD.CA eps by date.NGMD.CA eps by date.
N/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
NGMD.CA Yearly EPS VS EstimatesNGMD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 531.8K
359.24%		%
Q2 2024
Q2Q % growth		 14.9K
-34.07%		%
Q1 2024
Q2Q % growth		 47.4K
94.26%		%
Q2 2023
Q2Q % growth		 22.6K
-61.56%		%
NGMD.CA Yearly Revenue VS EstimatesNGMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 100K 200K 300K
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A